FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021183111> ?p ?o ?g. }

• W3021183111 abstract "Ocular neovascularisation underlies blinding eye diseases such as retinopathy of prematurity, proliferative diabetic retinopathy, and wet age-related macular degeneration. These diseases cause irreversible vision loss, and provide a significant health and economic burden. Biologics targeting vascular endothelial growth factor (VEGF) are the major approach for treatment. However, up to 30% of patients are non-responsive to these drugs and they are associated with ocular and systemic side effects. Therefore, there is a need for small molecule ocular angiogenesis inhibitors to complement existing therapies. We examined the safety and therapeutic potential of SH-11037, a synthetic derivative of the antiangiogenic homoisoflavonoid cremastranone, in models of ocular neovascularisation. SH-11037 dose-dependently suppressed angiogenesis in the choroidal sprouting assay ex vivo and inhibited ocular developmental angiogenesis in zebrafish larvae. Additionally, intravitreal SH-11037 (1 μM) significantly reduced choroidal neovascularisation (CNV) lesion volume in the laser-induced CNV mouse model, comparable to an anti-VEGF antibody. Moreover, SH-11037 synergised with anti-VEGF treatments in vitro and in vivo. Up to 100 μM SH-11037 was not associated with signs of ocular toxicity and did not interfere with retinal function or pre-existing retinal vasculature. SH-11037 is thus a safe and effective treatment for murine ocular neovascularisation, worthy of further mechanistic and pharmacokinetic evaluation." @default.
• W3021183111 created "2020-05-13" @default.
• W3021183111 creator A5002047549 @default.
• W3021183111 creator A5005073779 @default.
• W3021183111 creator A5043191941 @default.
• W3021183111 creator A5059483104 @default.
• W3021183111 creator A5061934056 @default.
• W3021183111 creator A5065767327 @default.
• W3021183111 creator A5068522765 @default.
• W3021183111 creator A5075017563 @default.
• W3021183111 creator A5087926905 @default.
• W3021183111 date "2016-05-05" @default.
• W3021183111 modified "2023-09-26" @default.
• W3021183111 title "A novel small molecule ameliorates ocular neovascularisation and synergises with anti-VEGF therapy" @default.
• W3021183111 hasPublicationYear "2016" @default.
• W3021183111 type Work @default.
• W3021183111 sameAs 3021183111 @default.
• W3021183111 citedByCount "0" @default.
• W3021183111 crossrefType "journal-article" @default.
• W3021183111 hasAuthorship W3021183111A5002047549 @default.
• W3021183111 hasAuthorship W3021183111A5005073779 @default.
• W3021183111 hasAuthorship W3021183111A5043191941 @default.
• W3021183111 hasAuthorship W3021183111A5059483104 @default.
• W3021183111 hasAuthorship W3021183111A5061934056 @default.
• W3021183111 hasAuthorship W3021183111A5065767327 @default.
• W3021183111 hasAuthorship W3021183111A5068522765 @default.
• W3021183111 hasAuthorship W3021183111A5075017563 @default.
• W3021183111 hasAuthorship W3021183111A5087926905 @default.
• W3021183111 hasConcept C118487528 @default.
• W3021183111 hasConcept C134018914 @default.
• W3021183111 hasConcept C141071460 @default.
• W3021183111 hasConcept C150903083 @default.
• W3021183111 hasConcept C167734588 @default.
• W3021183111 hasConcept C207001950 @default.
• W3021183111 hasConcept C26291073 @default.
• W3021183111 hasConcept C2776403814 @default.
• W3021183111 hasConcept C2776694085 @default.
• W3021183111 hasConcept C2777025900 @default.
• W3021183111 hasConcept C2777802072 @default.
• W3021183111 hasConcept C2778271429 @default.
• W3021183111 hasConcept C2778376644 @default.
• W3021183111 hasConcept C2779234561 @default.
• W3021183111 hasConcept C2779829184 @default.
• W3021183111 hasConcept C2779918416 @default.
• W3021183111 hasConcept C2780394083 @default.
• W3021183111 hasConcept C2780827179 @default.
• W3021183111 hasConcept C2781100027 @default.
• W3021183111 hasConcept C2781359195 @default.
• W3021183111 hasConcept C502942594 @default.
• W3021183111 hasConcept C54355233 @default.
• W3021183111 hasConcept C555293320 @default.
• W3021183111 hasConcept C71924100 @default.
• W3021183111 hasConcept C86803240 @default.
• W3021183111 hasConcept C98274493 @default.
• W3021183111 hasConceptScore W3021183111C118487528 @default.
• W3021183111 hasConceptScore W3021183111C134018914 @default.
• W3021183111 hasConceptScore W3021183111C141071460 @default.
• W3021183111 hasConceptScore W3021183111C150903083 @default.
• W3021183111 hasConceptScore W3021183111C167734588 @default.
• W3021183111 hasConceptScore W3021183111C207001950 @default.
• W3021183111 hasConceptScore W3021183111C26291073 @default.
• W3021183111 hasConceptScore W3021183111C2776403814 @default.
• W3021183111 hasConceptScore W3021183111C2776694085 @default.
• W3021183111 hasConceptScore W3021183111C2777025900 @default.
• W3021183111 hasConceptScore W3021183111C2777802072 @default.
• W3021183111 hasConceptScore W3021183111C2778271429 @default.
• W3021183111 hasConceptScore W3021183111C2778376644 @default.
• W3021183111 hasConceptScore W3021183111C2779234561 @default.
• W3021183111 hasConceptScore W3021183111C2779829184 @default.
• W3021183111 hasConceptScore W3021183111C2779918416 @default.
• W3021183111 hasConceptScore W3021183111C2780394083 @default.
• W3021183111 hasConceptScore W3021183111C2780827179 @default.
• W3021183111 hasConceptScore W3021183111C2781100027 @default.
• W3021183111 hasConceptScore W3021183111C2781359195 @default.
• W3021183111 hasConceptScore W3021183111C502942594 @default.
• W3021183111 hasConceptScore W3021183111C54355233 @default.
• W3021183111 hasConceptScore W3021183111C555293320 @default.
• W3021183111 hasConceptScore W3021183111C71924100 @default.
• W3021183111 hasConceptScore W3021183111C86803240 @default.
• W3021183111 hasConceptScore W3021183111C98274493 @default.
• W3021183111 hasLocation W30211831111 @default.
• W3021183111 hasOpenAccess W3021183111 @default.
• W3021183111 hasPrimaryLocation W30211831111 @default.
• W3021183111 hasRelatedWork W1969751359 @default.
• W3021183111 hasRelatedWork W1990363653 @default.
• W3021183111 hasRelatedWork W2009055235 @default.
• W3021183111 hasRelatedWork W2062742148 @default.
• W3021183111 hasRelatedWork W2095637752 @default.
• W3021183111 hasRelatedWork W2129208549 @default.
• W3021183111 hasRelatedWork W2333616114 @default.
• W3021183111 hasRelatedWork W2351105218 @default.
• W3021183111 hasRelatedWork W2368467196 @default.
• W3021183111 hasRelatedWork W2416235575 @default.
• W3021183111 hasRelatedWork W2539484214 @default.
• W3021183111 hasRelatedWork W2803761267 @default.
• W3021183111 hasRelatedWork W3036016789 @default.
• W3021183111 hasRelatedWork W3154234081 @default.
• W3021183111 hasRelatedWork W2592419978 @default.
• W3021183111 hasRelatedWork W2824168814 @default.
• W3021183111 hasRelatedWork W2835494556 @default.

• next